InterSystems deploys TrakCare with novel coronavirus screening functionality

InterSystems deploys TrakCare with novel coronavirus screening functionality

InterSystems is releasing global functionality for its TrakCare ® unified healthcare information system to screen and support patients with 2019-nCoV, the novel coronavirus infection that originated in Wuhan in China. The functionality is available to users of the latest editions of TrakCare now, and customers in China and multiple other countries, including the United Kingdom and United Arab Emirates have already begun using it. The functionality enables clinicians to screen patients for 2019-nCoV, using World Health Organization (WHO) guidance, and a link to the Wuhan Coronavirus Global Cases tracking app provided by the Johns Hopkins Center for Systems Science and Engineering in the US. Icons will indicate whether screening has been undertaken and the results. There is no generally accepted treatment for 2019-nCoV. However, the WHO is advising hospitals to isolate patients and protect others from infection, and the final element of the new TrakCare functionality will advise clinicians of any steps they should take. InterSystems keeps a close watch on the world’s healthcare requirements, so it can respond to issues that it can help to address in a timely manner. We are proud to have deployed this quickly for our users.” This is a great example of how TrakCare can be updated in real-time to urgently respond to threats and deployed rapidly to the organizations and clinicians that need it; particularly those using the latest edition of our systems.” Hazem El Oraby, MD, chief medical officer for TrakCare at InterSystems TrakCare is currently deployed in 27 countries around the globe, including China and throughout the Asia-Oceania region. Last week, TrakCare received a Best in KLAS designation for Global Electronic Medical Records in the Asia/Oceania region. Source:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More